gsk’s race to bring an rsv vaccine to market: cnbc healthy returns summit 2023
Published 1 year ago • 432 plays • Length 23:10Download video MP4
Download video MP3
Similar videos
-
4:49
moderna's mrna rsv vaccine propels stock gains
-
1:48
gsk on $2.1b vaccine supply deal with u.s.
-
2:04
sanofi, glaxosmithkline reach $2.1 billion deal with u.s. to supply vaccine doses
-
3:08
rsv virus cases among children spike early this year
-
4:24
jim cramer on sanofi & gsk partnership on coronavirus vaccine
-
6:59
ep 6: getting ahead of the health impacts of climate change
-
3:51
emma walmsley summarises our agreement with pfizer to form a consumer healthcare joint venture.
-
1:02:24
g-pst/esig webinar: ancillary services from an energy system with a high share of vre
-
1:30
rsv vaccines surprise manufacturers and analysts with early success
-
1:05
gsk, astrazeneca see virus-crisis boost
-
1:46
first rsv vaccine caps 60-year search to stem lung illness
-
3:39
rsv cases are rapidly increasing, health expert weighs in on vaccines
-
6:24
rsv cases continue to rise
-
22:38
unprecedented august spike in rsv concerns pediatric experts as covid-19 cases continue to rise
-
0:25
gsk asks fda to approve rsv vaccine for seniors
-
1:44
the gsk rsv vaccine is here. here's what it means for you | catalyst clips
-
0:20
final trades: pfizer, l3harris tech, the rsp and gdx
-
13:50
s5, ep 16- vaccine update: from the lag in covid-19 bivalent booster uptake to a future rsv vaccine
-
8:13
tripledemic: rsv, covid and flu with dr. siu ming geary | san diego health
-
2:02
race for gsk consumer healthcare
-
0:11
stay healthy today, enjoy more tomorrows
-
2:07
new rsv vaccine could be approved by the end of the year